SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare files DRHP with SEBI for Rs 2,100 crore IPO

06 Sep 2022 Evaluate

Blue Jet Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise as much as Rs 2,100 crore through an initial public offering (IPO).

Kotak Mahindra Capital Company, ICICI Securities, and J.P. Morgan India are the books running lead managers to the issue. The equity shares are proposed to be listed on BSE and NSE.

The Mumbai-based Blue Jet Healthcare, is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.

Blue Jet Healthcare Share Price

397.45 -9.85 (-2.42%)
13-Apr-2026 09:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1644.80
Dr. Reddys Lab 1210.40
Cipla 1205.20
Zydus Lifesciences 907.80
Lupin 2319.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×